Cardiology

Lipo-protein apheresis and PCSK9-inhibitors

Research suggests a specific treatment for Homozygous Familial Hypercholesterolaemic (HoFH) pateints; a combination therapy with PCSK9-inhibitors (PCSK9-I) and lipoprotein-apheresis (LA) may have synergistic effects on circulating ...

Diseases, Conditions, Syndromes

Buruli ulcer: Promising new drug candidate against a forgotten disease

Buruli ulcer, a neglected tropical disease, is debilitating and stigmatising. Affecting mainly children in West and Central Africa, the chronic disease results in devastating skin lesions and can lead to permanent disfigurement ...

HIV & AIDS

Combination therapy targets latent reservoir of HIV

With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

page 22 from 40